351 related articles for article (PubMed ID: 12901225)
21. [siRNA targeting telomerase--effective tool in anti-cancer therapy?].
Rubiś B; Półrolniczak A; Rybczyńska M
Postepy Biochem; 2008; 54(4):384-92. PubMed ID: 19248585
[TBL] [Abstract][Full Text] [Related]
22. Determination of telomerase activity and telomere length.
Wu KD; Moore MA
Methods Mol Med; 2005; 113():207-23. PubMed ID: 15968105
[TBL] [Abstract][Full Text] [Related]
23. Telomerase as an anti-cancer target: current status and future prospects.
Neidle S; Kelland LR
Anticancer Drug Des; 1999 Aug; 14(4):341-7. PubMed ID: 10625926
[TBL] [Abstract][Full Text] [Related]
24. Mechanism-based combination telomerase inhibition therapy.
Shay JW; Wright WE
Cancer Cell; 2005 Jan; 7(1):1-2. PubMed ID: 15652743
[TBL] [Abstract][Full Text] [Related]
25. Telomerase inhibitors.
Rowley PT; Tabler M
Anticancer Res; 2000; 20(6B):4419-29. PubMed ID: 11205282
[TBL] [Abstract][Full Text] [Related]
26. [Progress in telomerase and the inhibitors].
Zhou Y; Gong XG
Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):604-7. PubMed ID: 11910748
[TBL] [Abstract][Full Text] [Related]
27. Telomere maintenance as a target for anticancer drug discovery.
Neidle S; Parkinson G
Nat Rev Drug Discov; 2002 May; 1(5):383-93. PubMed ID: 12120414
[TBL] [Abstract][Full Text] [Related]
28. Telomerase as a diagnostic and therapeutic target for cancer.
Doyle LA; Highsmith WE
Expert Rev Anticancer Ther; 2002 Apr; 2(2):217-25. PubMed ID: 12113243
[TBL] [Abstract][Full Text] [Related]
29. Analysis of telomerase activity and telomere function in cancer.
Gordon KE; Parkinson EK
Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541
[TBL] [Abstract][Full Text] [Related]
30. Telomeres and telomerase: Pharmacological targets for new anticancer strategies?
Pendino F; Tarkanyi I; Dudognon C; Hillion J; Lanotte M; Aradi J; Ségal-Bendirdjian E
Curr Cancer Drug Targets; 2006 Mar; 6(2):147-80. PubMed ID: 16529544
[TBL] [Abstract][Full Text] [Related]
31. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells.
Chen Z; Koeneman KS; Corey DR
Cancer Res; 2003 Sep; 63(18):5917-25. PubMed ID: 14522918
[TBL] [Abstract][Full Text] [Related]
32. Telomerase as an emerging target to fight cancer--opportunities and challenges for nanomedicine.
Philippi C; Loretz B; Schaefer UF; Lehr CM
J Control Release; 2010 Sep; 146(2):228-40. PubMed ID: 20381558
[TBL] [Abstract][Full Text] [Related]
33. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
[TBL] [Abstract][Full Text] [Related]
34. Telomeres and telomerase: Biological and clinical importance in dogs.
Nasir L
Vet J; 2008 Feb; 175(2):155-63. PubMed ID: 17398127
[TBL] [Abstract][Full Text] [Related]
35. Telomerase inhibitors as anticancer therapy.
Akiyama M; Hideshima T; Munshi NC; Anderson KC
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):567-75. PubMed ID: 12678724
[TBL] [Abstract][Full Text] [Related]
36. Telomere maintenance mechanisms as a target for drug development.
Bearss DJ; Hurley LH; Von Hoff DD
Oncogene; 2000 Dec; 19(56):6632-41. PubMed ID: 11426649
[TBL] [Abstract][Full Text] [Related]
37. Targeting the telosome: therapeutic implications.
Folini M; Gandellini P; Zaffaroni N
Biochim Biophys Acta; 2009 Apr; 1792(4):309-16. PubMed ID: 19419699
[TBL] [Abstract][Full Text] [Related]
38. The cytotoxic effects of single-stranded telomere mimics on OMA-BL1 cells.
Page TJ; Mata JE; Bridge JA; Siebler JC; Neff JR; Iversen PL
Exp Cell Res; 1999 Oct; 252(1):41-9. PubMed ID: 10502398
[TBL] [Abstract][Full Text] [Related]
39. Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents.
Zhang W; Piatyszek MA; Kobayashi T; Estey E; Andreeff M; Deisseroth AB; Wright WE; Shay JW
Clin Cancer Res; 1996 May; 2(5):799-803. PubMed ID: 9816233
[TBL] [Abstract][Full Text] [Related]
40. Telomeres and telomerase as targets for cancer therapy.
Zimmermann S; Martens UM
Cell Mol Life Sci; 2007 Apr; 64(7-8):906-21. PubMed ID: 17310277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
